GT Biopharma Inc Tangible Net Worth Ratio
GT Biopharma Inc tangible net worth ratio. GT Biopharma Inc (GTBP) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($3.57 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of GT Biopharma Inc to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of GT Biopharma Inc (1983–2025)
Tangible net worth ratio of GT Biopharma Inc from 1983 to 2025. This chart shows how GT Biopharma Inc's Tangible Net Worth Ratio has changed across 31 annual periods from 1983 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $3.57 Million with intangible assets of $0.00 USD. See GTBP current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
GT Biopharma Inc Tangible Net Worth Ratio by Year (1983–2025)
GT Biopharma Inc tangible net worth ratio by year from 1983 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for GT Biopharma Inc from 1983 to 2025, covering 31 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see GTBP market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $5.79 Million | $0.00 | $8.11 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $7.48 Million | $0.00 | $14.11 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $11.73 Million | $0.00 | $16.74 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $21.91 Million | $0.00 | $32.17 Million | ▲ +222.2 pp |
| 2018 | -122.2% | $11.37 Million | $25.26 Million | $25.40 Million | ▼ -121.4 pp |
| 2017 | -0.8% | $251.69 Million | $253.78 Million | $254.37 Million | ▼ -66.4 pp |
| 2007 | 65.6% | $1.63 Million | $561.00K | $4.86 Million | ▲ +355.8 pp |
| 2006 | -290.3% | $195.00K | $761.00K | $8.00 Million | ▼ -366.8 pp |
| 2005 | 76.5% | $3.54 Million | $831.00K | $7.81 Million | ▼ -6.3 pp |
| 2004 | 82.8% | $5.80 Million | $995.00K | $8.48 Million | ▲ +67.1 pp |
| 2003 | 15.7% | $870.00K | $733.00K | $1.96 Million | ▼ -35.5 pp |
| 2002 | 51.2% | $1.22 Million | $594.00K | $1.99 Million | ▲ +31.2 pp |
| 2001 | 20.1% | $533.00K | $426.00K | $1.72 Million | ▼ -63.2 pp |
| 2000 | 83.3% | $4.07 Million | $681.00K | $5.62 Million | ▼ -16.7 pp |
| 1999 | 100.0% | $2.69 Million | $0.00 | $5.18 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $7.20 Million | $0.00 | $11.20 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $6.80 Million | $0.00 | $12.60 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $4.50 Million | $0.00 | $8.00 Million | ▲ +0.0 pp |
| 1995 | 100.0% | $4.30 Million | $0.00 | $9.90 Million | ▲ +0.0 pp |
| 1994 | 100.0% | $6.70 Million | $0.00 | $11.20 Million | ▲ +0.0 pp |
| 1993 | 100.0% | $2.80 Million | $0.00 | $3.10 Million | ▲ +0.0 pp |
| 1992 | 100.0% | $4.30 Million | $0.00 | $4.90 Million | ▲ +0.0 pp |
| 1991 | 100.0% | $4.60 Million | $0.00 | $4.80 Million | ▲ +0.0 pp |
| 1990 | 100.0% | $4.80 Million | $0.00 | $5.00 Million | ▲ +0.0 pp |
| 1989 | 100.0% | $3.90 Million | $0.00 | $4.40 Million | ▲ +0.0 pp |
| 1988 | 100.0% | $3.20 Million | $0.00 | $3.50 Million | ▲ +0.0 pp |
| 1987 | 100.0% | $3.10 Million | $0.00 | $3.30 Million | ▲ +0.0 pp |
| 1986 | 100.0% | $2.80 Million | $0.00 | $3.30 Million | ▲ +0.0 pp |
| 1985 | 100.0% | $3.10 Million | $0.00 | $3.20 Million | ▲ +0.0 pp |
| 1984 | 100.0% | $3.50 Million | $0.00 | $3.80 Million | ▲ +0.0 pp |
| 1983 | 100.0% | $3.10 Million | $0.00 | $3.50 Million | — |